X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with AANJANEYA LIFECARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA DR. DATSONS LABS SHASUN PHARMA/
DR. DATSONS LABS
 
P/E (TTM) x 123.9 -10.9 - View Chart
P/BV x 8.5 0.2 5,255.6% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHASUN PHARMA   DR. DATSONS LABS
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
DR. DATSONS LABS
Mar-14
SHASUN PHARMA/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs94126 75.0%   
Low Rs4631 147.6%   
Sales per share (Unadj.) Rs214.2133.0 161.0%  
Earnings per share (Unadj.) Rs5.30.2 3,519.5%  
Cash flow per share (Unadj.) Rs15.86.6 239.4%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.3128.8 41.4%  
Shares outstanding (eoy) m56.6231.66 178.8%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x0.30.6 55.5%   
Avg P/E ratio x13.1516.1 2.5%  
P/CF ratio (eoy) x4.411.8 37.3%  
Price / Book Value ratio x1.30.6 215.7%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,9582,477 159.8%   
No. of employees `000NANA-   
Total wages/salary Rs m2,16456 3,863.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,1274,211 288.0%  
Other income Rs m22979 291.4%   
Total revenues Rs m12,3564,289 288.1%   
Gross profit Rs m1,009569 177.5%  
Depreciation Rs m594204 290.4%   
Interest Rs m415430 96.5%   
Profit before tax Rs m23013 1,808.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 16.7%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-736 -1,192.1%   
Profit after tax Rs m3025 6,294.2%  
Gross profit margin %8.313.5 61.6%  
Effective tax rate %-31.748.0 -65.9%   
Net profit margin %2.50.1 2,185.4%  
BALANCE SHEET DATA
Current assets Rs m6,8846,852 100.5%   
Current liabilities Rs m8,4566,711 126.0%   
Net working cap to sales %-13.03.3 -387.0%  
Current ratio x0.81.0 79.7%  
Inventory Days Days62161 38.3%  
Debtors Days Days108318 33.8%  
Net fixed assets Rs m4,9703,673 135.3%   
Share capital Rs m113317 35.8%   
"Free" reserves Rs m2,8753,761 76.4%   
Net worth Rs m3,0204,078 74.1%   
Long term debt Rs m1,8171,671 108.8%   
Total assets Rs m13,34712,633 105.7%  
Interest coverage x1.61.0 150.9%   
Debt to equity ratio x0.60.4 146.9%  
Sales to assets ratio x0.90.3 272.6%   
Return on assets %5.43.4 156.1%  
Return on equity %10.00.1 8,497.6%  
Return on capital %13.37.7 173.6%  
Exports to sales %46.422.9 202.5%   
Imports to sales %14.214.3 99.7%   
Exports (fob) Rs m5,622964 583.1%   
Imports (cif) Rs m1,728602 287.0%   
Fx inflow Rs m5,843964 606.1%   
Fx outflow Rs m2,173607 358.0%   
Net fx Rs m3,669357 1,028.2%   
CASH FLOW
From Operations Rs m3981,345 29.6%  
From Investments Rs m-1,635-2,256 72.5%  
From Financial Activity Rs m1,309-1,200 -109.1%  
Net Cashflow Rs m71-2,111 -3.4%  

Share Holding

Indian Promoters % 39.2 4.5 865.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 0.0 -  
FIIs % 17.6 1.4 1,303.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 94.1 42.1%  
Shareholders   20,750 20,807 99.7%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ABBOTT INDIA  NATCO PHARMA  DIVIS LABORATORIES  PFIZER  ALKEM LABORATORIES  

Compare SHASUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; IT Stocks Witness Buying Interest(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the IT sector and FMCG sector witnessing maximum buying interest.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - NOVARTIS COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS